Status:
TERMINATED
Complex Cutaneous Leishmaniasis Healing Study in Algeria
Lead Sponsor:
K. W. Stahl
Collaborating Sponsors:
Institut Pasteur
University of Erlangen-Nürnberg Medical School
Conditions:
Cutaneous Leishmaniases
Eligibility:
All Genders
1-90 years
Brief Summary
This study evaluates the effect of clean wound management and dressing on complex zoonotic cutaneous leishmaniasis caused by L. major in the MENA region (Algeria). The patients will participate in the...
Detailed Description
The investigator initiated, non-interventional LeiClean Trial with 100 CL patients presenting complex CL lesions, normally in need of a systemic an in-door treatment with meglumine antimoniate and in ...
Eligibility Criteria
Inclusion
- Subject has Giemsa and PCR proven L.major cutaneous leishmaniasis
- Subject has complex zoonotic cutaneous leishmaniasis or Sb(V) incompatibility
- Subject gives voluntary consent
Exclusion
- Immune deficiencies, skin tumours, allergy to 1,2-propylene glycol (rare)
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03292835
Start Date
November 1 2017
End Date
November 15 2020
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NGO Waisenmedizin e. V.
Freiburg im Breisgau, Germany, 79100